Supplemental material
Open access
1,888
Views
4
CrossRef citations to date
0
Altmetric
Report
Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2
Meghan M. Verstraetea Zymeworks Inc, Vancouver, CanadaCorrespondence[email protected]
https://orcid.org/0000-0003-0422-2826View further author information
Florian Heinkela Zymeworks Inc, Vancouver, Canada
https://orcid.org/0000-0002-2383-9330View further author information
Janessa Lia Zymeworks Inc, Vancouver, CanadaView further author information
, Siran Caoa Zymeworks Inc, Vancouver, CanadaView further author information
, Anh Tranb Department of Human Health Therapeutics, National Research Council Canada, Ottawa, Canada
https://orcid.org/0000-0003-0644-6014View further author information
Elizabeth C. Halversona Zymeworks Inc, Vancouver, CanadaView further author information
, Robert Genea Zymeworks Inc, Vancouver, CanadaView further author information
, Elizabeth Stanglea Zymeworks Inc, Vancouver, CanadaView further author information
, Begonia Silva-Morenoa Zymeworks Inc, Vancouver, CanadaView further author information
, Sifa Arrafia Zymeworks Inc, Vancouver, CanadaView further author information
, Jegarubee Bavananthasivamb Department of Human Health Therapeutics, National Research Council Canada, Ottawa, Canada
https://orcid.org/0000-0002-0332-4823View further author information
Madeline Funga Zymeworks Inc, Vancouver, CanadaView further author information
, Mariam Eji-Lasisia Zymeworks Inc, Vancouver, CanadaView further author information
, Stephanie Mastermana Zymeworks Inc, Vancouver, CanadaView further author information
, Steve Xanthoudakisa Zymeworks Inc, Vancouver, CanadaView further author information
, Surjit Dixita Zymeworks Inc, Vancouver, CanadaView further author information
, John Babcooka Zymeworks Inc, Vancouver, CanadaView further author information
, Brandon Clavettea Zymeworks Inc, Vancouver, CanadaView further author information
, Mark Fogga Zymeworks Inc, Vancouver, CanadaView further author information
& Eric Escobar-Cabreraa Zymeworks Inc, Vancouver, Canada
https://orcid.org/0000-0002-2749-8860View further author information
Article: 2212415
|
Received 03 Jan 2023, Accepted 05 May 2023, Published online: 25 May 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.